Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

German health reform hits Beiersdorf's sales:

This article was originally published in Clinica

Executive Summary

Beiersdorf's domestic medical sales continue to be hit by the effects of German health reform and subsequent uncertainty following "complicated" regulatory change. Total sales in this division fell 1.6% to DM756 million ($427 million) in the first half of 1998, as a result of reduced sales in Germany. The Hamburg-based company's group sales were DM3,420 million, up 6%, with net income of DM159 million, compared with DM146 million - excluding restructuring costs - in the previous first half.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT083309

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel